143 related articles for article (PubMed ID: 38072495)
1. Assessing the risk of COVID-19 reinfection and severe outcomes among individuals with substance use disorders: a retrospective study using real-world electronic health records.
Tuan WJ; Kindt HM; Lennon RP
BMJ Open; 2023 Dec; 13(12):e074993. PubMed ID: 38072495
[TBL] [Abstract][Full Text] [Related]
2. Impact of Cannabis Use, Substance Use Disorders, and Psychiatric Diagnoses on COVID-19 Outcomes: A Retrospective Cohort Study.
Ramakrishnan D; Sureshanand S; Pittman B; Radhakrishnan R
J Clin Psychiatry; 2022 Aug; 83(5):. PubMed ID: 36044600
[No Abstract] [Full Text] [Related]
3. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings.
Winhusen T; Theobald J; Kaelber DC; Lewis D
Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217
[TBL] [Abstract][Full Text] [Related]
4. Increased Morbidity and Mortality in Hypertensive Patients With Substance Use Disorders: Electronic Health Record Findings.
Winhusen T; Theobald J; Kaelber DC; Lewis D
J Stud Alcohol Drugs; 2020 Jul; 81(4):471-478. PubMed ID: 32800083
[TBL] [Abstract][Full Text] [Related]
5. Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records.
Hasin DS; Fink DS; Olfson M; Saxon AJ; Malte C; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Livne O; Mannes ZL; Sherman SE; Wall MM
Drug Alcohol Depend; 2022 May; 234():109383. PubMed ID: 35279457
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States.
Wang QQ; Kaelber DC; Xu R; Volkow ND
Mol Psychiatry; 2021 Jan; 26(1):30-39. PubMed ID: 32929211
[TBL] [Abstract][Full Text] [Related]
7. High Risk of Alcohol-Impaired Driving in Adults With Comorbid Alcohol and Substance Use Disorders in the U.S. Population.
Roberts W; Moore KE; Pittman BP; Fillmore MT; McKee SA
J Stud Alcohol Drugs; 2019 Jan; 80(1):114-119. PubMed ID: 30807283
[TBL] [Abstract][Full Text] [Related]
8. Hospitalization Associated With Comorbid Psychiatric and Substance Use Disorders Among Adults With COVID-19 Treated in US Emergency Departments From April 2020 to August 2021.
Schieber LZ; Dunphy C; Schieber RA; Lopes-Cardozo B; Moonesinghe R; Guy GP
JAMA Psychiatry; 2023 Apr; 80(4):331-341. PubMed ID: 36790774
[TBL] [Abstract][Full Text] [Related]
9. Associations of alcohol use disorder, cannabis use disorder, and nicotine dependence with concurrent opioid use disorder in U.S. adults.
Harton MR; Adams ZW; Parker MA
Exp Clin Psychopharmacol; 2023 Dec; 31(6):998-1004. PubMed ID: 37166911
[TBL] [Abstract][Full Text] [Related]
10. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
[TBL] [Abstract][Full Text] [Related]
11. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
[TBL] [Abstract][Full Text] [Related]
12. Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021.
Wang L; Wang Q; Davis PB; Volkow ND; Xu R
World Psychiatry; 2022 Feb; 21(1):124-132. PubMed ID: 34612005
[TBL] [Abstract][Full Text] [Related]
13. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
14. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
[TBL] [Abstract][Full Text] [Related]
15. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
Nordström P; Ballin M; Nordström A
Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study.
Tartof SY; Slezak JM; Puzniak L; Hong V; Frankland TB; Ackerson BK; Xie F; Takhar H; Ogun OA; Simmons S; Zamparo JM; Valluri SR; Jodar L; McLaughlin JM
Lancet Respir Med; 2023 Dec; 11(12):1089-1100. PubMed ID: 37898148
[TBL] [Abstract][Full Text] [Related]
17. Incidence of and risk factors for suspected COVID-19 reinfection in Kyoto City: a population-based epidemiological study.
Nagao M; Matsumura Y; Yamamoto M; Shinohara K; Noguchi T; Yukawa S; Tsuchido Y; Teraishi H; Inoue H; Ikeda T
Eur J Clin Microbiol Infect Dis; 2023 Aug; 42(8):973-979. PubMed ID: 37273038
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 complications among patients with opioid use disorder: a retrospective cohort study across five major NYC hospital systems.
Krawczyk N; Rivera BD; Basaraba C; Corbeil T; Allen B; Schultebraucks K; Henry BF; Pincus HA; Levin FR; Martinez D
Addiction; 2023 May; 118(5):857-869. PubMed ID: 36459420
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
Al-Otaiby M; Krissaane I; Al Seraihi A; Alshenaifi J; Qahtani MH; Aljeri T; Zaatari E; Hassanain M; Algwizani A; Albarrag A; Al-Mozaini M; Alabdulaali M
Int J Infect Dis; 2022 Sep; 122():758-766. PubMed ID: 35840098
[TBL] [Abstract][Full Text] [Related]
20. National Prevalence of Alcohol and Other Substance Use Disorders Among Emergency Department Visits and Hospitalizations: NHAMCS 2014-2018.
Suen LW; Makam AN; Snyder HR; Repplinger D; Kushel MB; Martin M; Nguyen OK
J Gen Intern Med; 2022 Aug; 37(10):2420-2428. PubMed ID: 34518978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
